Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Acta Gastro-Enterologica Belgica|January 6, 2026
Chronic hepatitis E in immunosuppressed patients: a comprehensive review of the literatureM Philippart, T Vanwolleghem, G Dahlqvist
Acta Gastro-Enterologica Belgica|October 24, 2018
Cytomegalovirus pleuropericarditis after orthotopic liver transplantationJ Meesters, L Beckers, S Francque, et al.
Acta Gastro-Enterologica Belgica|February 17, 2025
An unusual case of acute cholestatic hepatitis: visceral leishmaniasis with secondary haemophagocytic lymphohistiocytosisN Gestels, E Bottieau, A De Vooght, et al.
Acta Gastro-Enterologica Belgica|February 17, 2025
Unexplained portal hypertension and confusion in an elderly patient: a late presentation of congenital hepatic fibrosisB Rombouts, E Van der Wijst, P Schoeters, et al.
Acta Gastro-Enterologica Belgica|February 28, 2021
Comorbidities and concomitant medications in patients with chronic hepatitis C virus infection receiving second-generation direct-acting antiviral regimens in Belgium: an observational studyS Bourgeois, J P Mulkay, M Cool, et al.
Acta Gastro-Enterologica Belgica|January 6, 2026
SBP: Always peritonitis in decompensated cirrhosis? Case report and review of the literatureY Van Loocke, W Kwanten, J Derdeyn, et al.
Acta Diabetologica|October 21, 2020
Association of 1-deoxy-sphingolipids with steatosis but not steatohepatitis nor fibrosis in non-alcoholic fatty liver diseaseJ Weyler, A Verrijken, T Hornemann, et al.
Acta Gastro-Enterologica Belgica|July 1, 2020
Liver transplantation during the COVID-19 epidemic : recommendations from the Belgian Liver Intestine Transplant Committee (BeLIAC)G Dahlqvist, O Ciccarelli, H Van Vlierberghe, et al.
Journal of Viral Hepatitis|May 16, 2017
The risk of early occurrence and recurrence of hepatocellular carcinoma in hepatitis C-infected patients treated with direct-acting antivirals with and without pegylated interferon: A Belgian experienceR Bielen, C Moreno, H Van Vlierberghe, et al.
Alimentary Pharmacology & Therapeutics|March 3, 2018
Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomesS Van Hees, S Bourgeois, H Van Vlierberghe, et al.
Pageof 2